Black Diamond Therapeutics Inc. - Wutah bathi EPS kuartalan BDTX

Logo korporat perusahaan Black Diamond Therapeutics (BDTX)

Quarterly EPS variation demonstrates yield dynamics, where the metric level stands at -16.80. Black Diamond (BDTX) audience growth is tied to FDA decisions, as the commercial segment has not yet been established. Business stability is ensured by a lack of seasonality and macroeconomic resilience. Development relies on scientific alliances with oncology centers to combat rare genetic mutations.

Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan blackdiamondtherapeutics.com (BDTX): kanggo periode 04.07.2022 - 15.11.2026

Rincian analitis perusahaan Black Diamond

Pambiji fundamental perusahaan:blackdiamondtherapeutics.com - BDTX
Barang unggulan blackdiamondtherapeutics.com

Black Diamond (BDTX) is developing high-tech targeted cancer therapy methods under venture risk conditions. This indicator captures the percentage change in earnings per share (EPS) per quarter, separating fundamental growth from market noise. Investors utilize this tool to verify the actual efficiency of the business. The quarterly EPS growth trend allows for an assessment of the company's resilience to speculative volatility. Analyzing this chart helps determine the entry point, minimizing the risk of purchasing the asset at the peak of unjustified optimism.

Analisis perusahaan pesaing

GMAB (Genmab) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|EXEL: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|NUVL (Nuvalent Therapeutics) - Wutah bathi EPS kuartalan|Wutah bathi EPS kuartalan kymeratx.com|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan IDEAYA Biosciences, Inc. (IDYA)|ELVN (Enliven Therapeutics, Inc.) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan ORIC (ORIC Pharmaceuticals Inc)|Wutah bathi resik saben saham sajroning taun lumaku Relay Pharma|Nurix Therapeutics Inc - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Tyra Biosciences|VSTM (Verastem, Inc.) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|GLUE: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|CGEM (cullinanoncology.com) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Immuneering Inc. IMRX|Wutah bathi EPS kuartalan CCCC|Repare Therapeutics Inc. - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|PMV Pharmaceuticals, Inc. - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan KPTI|PPCB: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Cyclacel Pharmaceuticals - Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|AADI: Wutah bathi EPS kuartalan|Aileron Therapeutics Inc - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|BPMC (Blueprint Medicines Corp.) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan glycomimetics.com GLYC|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan SpringWorks (SWTX)